We believe that every human in a need of an organ transplant should be able to get it immediately
/
APR 10, 2025
InPres LLC is a biomaterial preservation technology company. Our r&d started in 2011 with successful experimental preservation of skin grafts and erythrocytes in a gas mixture for a period of 30 days. As people age, the wear and tear on individual organs—such as the heart, lungs, liver, or kidneys—becomes a limiting factor, outpacing the body's overall ability to sustain longevity.

We believe that every human in a need of an organ transplant should be able to get it immediately.

To achieve this a significant enhancement of the organ preservation and delivery is required to withstand both organ deterioration and logistical challenges.


We develop cost efficient and reliable organ preservation technology and device that allow dramatic increase procurement distance with no load on organ quality.s.
We believe that every human in a need of an organ transplant should be able to get it immediately
InPres LLC is a biomaterial preservation technology company. Our r&d started in 2011 with successful experimental preservation of skin grafts and erythrocytes in a gas mixture for a period of 30 days. As people age, the wear and tear on individual organs—such as the heart, lungs, liver, or kidneys—becomes a limiting factor, outpacing the body's overall ability to sustain longevity.

We believe that every human in a need of an organ transplant should be able to get it immediately.

To achieve this a significant enhancement of the organ preservation and delivery is required to withstand both organ deterioration and logistical challenges.


We develop cost efficient and reliable organ preservation technology and device that allow dramatic increase procurement distance with no load on organ quality.s.
News and press releases
Rat study phase completed
FEBRUARY 11, 2025
FEBRUARY 11, 2025
Rat study phase completed
FEBRUARY 11, 2025
Rat study phase completed
FEBRUARY 11, 2025
Rat study phase completed
NOVEMBER 2024
InPres brings heart back to life
SEPTEMBER 10, 2024
Custodiol fails: no heartbeat after 12 hours
APRIL 4, 2025
Clinical trial confirms 11-hour heart viability
APRIL 4, 2025
Clinical trial confirms 11-hour heart viability